Phenobarbitone: Indian Epilepsy Society- Consensus Document

Man Mohan Mehndiratta; Satish Jain; Parampreet S. Kharbanda; Pravina Shah; Manjari Tripathi; Sita Jayalakshmi; Sheffali Gulati; Suvasini Sharma; Sangeeta Ravat

doi:10.1016/S2213-6320(15)00063-9

International Journal of Epilepsy, Inhaltsverzeichnis

International Journal of Epilepsy 2015; 02(02): 101-105
DOI: 10.1016/S2213-6320(15)00063-9

Original Article

Thieme Medical and Scientific Publishers Private Ltd.

Phenobarbitone: Indian Epilepsy Society- Consensus Document

Authors

Man Mohan Mehndiratta

^aJanakpuri Super Speciality Hospital, New Delhi
Satish Jain

^bIndian Epilepsy Centre, New Delhi
Parampreet S. Kharbanda

^cPostgraduate Institute of Medical Education & Research (PGIMER), Chandigarh
Pravina Shah

^dFortis Hospital, Mulund, Mumbai, Maharashtra
Manjari Tripathi

^eAll India Institute of Medical Sciences New Delhi
Sita Jayalakshmi

^fKrishna Institute of Medical Sciences, Secunderabad, Telangana
Sheffali Gulati

^gAll India Institute of Medical Sciences, New Delhi
Suvasini Sharma

^hLady Hardinge Medical College and Associated Kalawati Saran Children's Hospital, New Delhi
Sangeeta Ravat

ⁱSeth G.S. Medical College and King Edward Memorial Hospital Mumbai

Verantwortlicher Herausgeber dieser Rubrik:

Abstract

Volltext

Referenzen

References
1 Ilangaratne NB, Mannakkara NN, Bell GS, Sander JW. Phenobarbital: missing in action. Bull World Health Organ 2012; 90: 871-871A
2 World Health Organization. Division of Mental Health. Initiative of Support to People with Epilepsy. Geneva: World Health Organization; 1990. (document WHO/MNH/MND/90.3)
3 Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 1990; 42: 223-286
4 Twyman RE, Rogers CJ, Macdonald RL. Differential regulation of g-amino butyric acid receptor channels by diazepam and Phenobarbital. Ann Neurol 1989; 25: 213-220
5 Seeman P. Membrane actions of anesthetics and tranquilizers. Pharmacol Rev 1972; 24: 583-656
6 Booker HE. Phenobarbital. Relation of plasma concentration to seizure control. In: Antiepileptic Drugs Woodbury DM, Penry JK, Pippenger DE. (Eds.) New York: Raven Press; 1982: 341-50
7 Wilmshurst JM, van Toorn R. Use of phenobarbitone for treating childhood epilepsy in resource-poor countries. S Afr Med J 2005; 95: 392-394, 396
8 Gursahani R. Phenobarbitone in modern India. J Assoc Physicians India 2013; 61 (08) Suppl 45-47
9 Pal DK. Phenobarbital for childhood epilepsy: systematic review. Paediatr Perinat Drug Ther 2006; 7: 31-42
10 Glauser T, Ben-Menachem E, Bourgeois B. et al Updated ILA. evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2013; 54: 551-563
11 Kwan P, Brodie JM. Invited review: phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 2004; 45: 1141-1149
12 NICE guidelines update 2013. The diagnosis and management of the epilepsies in adults and children in primary and secondary care. Available at: http://www.nice.org.uk/guidance/cg137/resources/guidance-theepilepsies-the-diagnosisand-management-of-theepilepsies-in-adults-and-children-in-primary-andsecondary-care-pdf (Accessed on 12th October 2014).
13 Mewasingh LD. Febrile seizures. Clin Evid (Online) 2010; 2010: pii-0324
14 Offringa M, Newton R. Prophylactic drug management for febrile seizures in children. Cochrane Database Syst Rev 2012; CD003031
15 Goldberg MA, McIntyre HB. Barbiturates in the treatment of status epilepticus. Adv Neurol 1983; 34: 499-503
16 Treiman DM, Meyers PD, Walton NY. et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998; 339: 792-798
17 Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a metaanalysis of published studies. Seizure 2014; 23: 167-174
18 Brigo F, Igwe SC, Nardone R. et al. A common reference-based indirect comparison meta-analysis of intravenous valproate versus intravenous phenobarbitone for convulsive status epilepticus. Epileptic Disord 2013; 15: 314-323
19 Tiamkao S, Mayurasakorn N, Suko P. et al. Very high dose phenobarbital for refractory status epilepticus. J Med Assoc Thai 2007; 90: 2597-2600
20 Lee WK, Liu KT, Young BW. Very-high-dose phenobarbital for childhood refractory status epilepticus. Pediatr Neurol 2006; 34: 63-65
21 Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR. Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology 1988; 38: 1035-1040
22 Tomson T, Battino D, Bonizzoni E. et al. EURAP Study Group. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011; 10: 609-617
23 Kwan P, Brodie MJ. Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 2004; 45: 1141-1149
24 Tripathi M, Jain DC, Devi MG. et al. Need for a national epilepsy control program. Ann Indian Acad Neurol 2012; 15: 89-93
25 Brodie MJ, Kwan P. Current position of phenobarbital in epilepsy and its future. Epilepsia 2012; 53 (Suppl (08) 40-46
26 Kale R, Perucca E. Revisiting phenobarbital for epilepsy. BMJ 2004; 329: 1199-1200